Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × Magnetic Resonance Spectroscopy × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 82 Lung Neoplasms 56 Carcinoma, Non-Small-Cell Lung 48 Breast Neoplasms 46 Neoplasm Metastasis 44 Glioma 34 Glioblastoma 33 Multiple Myeloma 31 Carcinoma, Renal Cell 30 Brain Neoplasms 30 Pancreatic Neoplasms 27 Lymphoma, Large B-Cell, Diffuse 24 Urinary Bladder Neoplasms 23 Melanoma 23 Colorectal Neoplasms 22 Triple Negative Breast Neoplasms 21 Ovarian Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 18 Carcinoma, Hepatocellular 18 Oropharyngeal Neoplasms 17 Mouth Neoplasms 17 Lymphoma, Follicular 17 Lymphoma 15 Sarcoma 14 Fallopian Tube Neoplasms 14 Carcinoma, Transitional Cell 14 Carcinoma 14 Leukemia, Lymphocytic, Chronic, B-Cell 13 Laryngeal Neoplasms 13 Astrocytoma 13

Interventions

Specimen Handling 7 Tamoxifen 5 Practice Guidelines as Topic 5 Standard of Care 4 Radiotherapy 3 Methods 3 Sentinel Lymph Node Biopsy 2 Radiation 2 Interviews as Topic 2 Educational Status 2 Early Intervention, Educational 2 Counseling 2 pembrolizumab 1 exemestane 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 abemaciclib 1 Watchful Waiting 1 Telemedicine 1 Taxes 1 Tablets 1 Surveys and Questionnaires 1 Starch 1 Reverse Transcriptase Polymerase Chain Reaction 1 Ranitidine 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Protons 1 Proton Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671912 2026-03-04

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡